Skip to content

Clinical trials

Completed Phase 1 Liver Cirrhosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis Phase: Phase 1 Status: Completed Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20082
20093
20102
20111
20121
20141
20152
20171
20182
20191
20216
20222
20232
20241
20256
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Beijing Continent Pharmaceutical Co, Ltd.3
Norgine3
GlaxoSmithKline2
Alentis Therapeutics AG1
Boehringer Ingelheim1
Bristol-Myers Squibb1
British University In Egypt1
Eli Lilly and Company1
Galecto Biotech AB1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis37
Non-alcoholic Fatty Liver Disease4
Fibrosis3
Ascites2
Hepatitis C2
Alcoholism1
Carcinoma, Hepatocellular1
Fatty Liver1
Hemophilia A1
Hepatic Encephalopathy1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.